Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

802
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
802

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term outcomes of lung transplantation in the elderly: an analysis using the UNOS database.

Journal of thoracic disease·2026
Same author

Large Language Models Utility for Rapid On-Site Evaluation in Interventional Pulmonology.

Diagnostics (Basel, Switzerland)·2026
Same author

CT-Guided Lung Biopsy Using Dual-Energy Iodine Mapping to Target Lung Masses with Necrotic Tissue-A Proof-of-Concept Study.

Journal of clinical medicine·2026
Same author

Cerebral Tissue Pulmonary Embolism Masquerading as Primary Graft Dysfunction After Lung Transplantation.

Pulmonary circulation·2026
Same author

Bone Health in Young Lung Transplant Recipients: A Retrospective Study.

Respiration; international review of thoracic diseases·2026
Same author

Sex Disparities in Mortality Outcomes Among COPD Patients Awaiting Lung Transplantation: A Comprehensive Analysis.

The Israel Medical Association journal : IMAJ·2025
Same journal

Towards haplotypes of blood group genes: the impact of long-read sequencing in molecular immunohematology.

Annals of translational medicine·2026
Same journal

Development of pharmacological interventions for the treatment of sarcopenia.

Annals of translational medicine·2026
Same journal

Fertility preservation in young women with breast cancer: a narrative review of effectiveness, oncologic safety, and clinical practice implications.

Annals of translational medicine·2026
Same journal

Propofol-based total intravenous anesthesia and recurrence-free survival after hepatectomy-does it improve outcomes?

Annals of translational medicine·2026
Same journal

Is pulmonary hypertension still a contraindication for lung volume reduction?-a narrative review of contemporary evidence.

Annals of translational medicine·2026
Same journal

Calcium montmorillonite clay: a clinically oriented narrative review of emerging perioperative and supportive applications.

Annals of translational medicine·2026
See all related articles

Related Experiment Video

Updated: Dec 22, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.3K

Malignancy after lung transplantation.

Osnat Shtraichman1,2, Vivek N Ahya1

  • 1Pulmonary, Allergy and Critical Care Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Annals of Translational Medicine
|May 2, 2020
PubMed
Summary
This summary is machine-generated.

Lung transplant recipients face increased cancer risks due to long-term immunosuppression. This review details common post-transplant malignancies, their causes, and management strategies for improved survival.

Keywords:
Lung transplantimmunosuppressionmalignancyrisk factors

More Related Videos

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

17.9K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.8K

Related Experiment Videos

Last Updated: Dec 22, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.3K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

17.9K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.8K

Area of Science:

  • Immunology
  • Oncology
  • Transplantation Medicine

Background:

  • Lung transplantation offers a therapeutic option for advanced lung diseases, but long-term survival is challenged by chronic conditions.
  • Post-transplant malignancy is the second leading cause of death 5-10 years after lung transplantation.
  • Chronic immunosuppressive therapy impairs anti-tumor immune surveillance, increasing cancer risk, particularly in lung transplant recipients who receive higher doses.

Purpose of the Study:

  • To review common malignancies after lung transplantation.
  • To identify risk factors, prognosis, and current prevention and treatment strategies for post-transplant cancers.
  • To highlight the elevated cancer risk in lung transplant recipients compared to other solid organ transplant populations.

Main Methods:

  • Literature review of studies on post-transplant malignancies in lung transplant recipients.
  • Analysis of cancer incidence, risk factors, and outcomes.
  • Synthesis of current guidelines for prevention and treatment.

Main Results:

  • Non-melanoma skin cancers are the most frequent malignancies, followed by lung cancer and post-transplant lymphoproliferative disorder (PTLD).
  • Immunosuppression is a key factor in cancer development.
  • Lung transplant recipients have a higher risk of developing cancer.

Conclusions:

  • Cancer is a significant long-term complication of lung transplantation.
  • Effective management requires understanding risk factors and implementing tailored prevention and treatment strategies.
  • Further research is needed to optimize long-term outcomes and reduce cancer burden in this population.